BD (Becton, Dickinson and Company) and Ypsomed recently expanded their collaboration to develop a 5.5 mL BD Neopak XtraFlow Glass Prefillable Syringe compatible with Ypsomed's YpsoMate 5.5 ...
New solution extends BD UltraSafe Plus™ needle guard platform capabilities to deliver up to 2 mL and 30 cP biologics – enhancing self-administration FRANKLIN LAKES, NJ, USA, November 17, 2021 / B3C ...
BD (Becton, Dickinson and Company), a global medical technology company, has announced the completion of a 50-subject human clinical trial with the BD Libertas™ Wearable Injector. The injector is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results